Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Drops 23 Points. More details...
Fed Announcement Drives Biotech Higher. More details...
CBT 200 Books Another Big Gain. More details...
CBT 200 Takes A Small Loss. More details...
If You Were Big, You Probably Got Bigger. More details...
CBT 200 Gains 43 Points Or 1.1%. More details...
Lots Of News; Lots Of Enthusiasm. More details...
CBT 200 Drops .66%. More details...
Newsflow Is Still Heavy. More details...
Strong Announcement Flow As Confab Winds Down. More...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
